Atlas Trials

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

Clinical trial NCT07149363 · RECRUITING

Trial details

NCT number
NCT07149363
Sponsor
Alliance Foundation Trials, LLC.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer (SCLC)
Start date
2026-02-12
Primary completion
2029-02-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.